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Selective embolization of the internal iliac arteries for 
the treatment of intractable hemorrhage in children 
with malignancies
Purpose: Acute internal hemorrhage is an occasionally life-threatening 
complication in pediatric cancer patients. Many therapeutic 
approaches have been used to control bleeding with various degrees 
of success. In this study, we evaluated the efficacy of selective internal 
iliac artery embolization for controlling acute intractable bleeding in 
children with malignancies. 
Methods: We retrospectively evaluated the cases of 6 children 
with various malignancies (acute lymphoblastic leukemia, acute 
myelogenous leukemia, chronic myelogenous leukemia, T-cell 
prolymphocytic leukemia, Langerhans cell histiocytosis, and 
rhabdomyosarcoma), who had undergone selective arterial 
embolization (SAE) of the internal iliac artery at the Chonnam National 
University Hwasun Hospital between January 2004 and December 
2009. SAE was performed by an interventional radiologist using 
Gelfoam
Ⓡ and/or Tornado
Ⓡ coils. 
Results: The patients were 5 boys and 1 girl with median age of 6.9 
years (range, 0.7–14.8 years) at the time of SAE. SAE was performed 
once in 4 patients and twice in 2, and the procedure was unilateral 
in 2 and bilateral in 4. The causes of hemorrhage were as follows: 
hemorrhagic cystitis (HC) in 3 patients, procedure-related internal 
iliac artery injuries in 2 patients, and tumor rupture in 1 patient. 
Initial attempt at conservative management was unsuccessful. Of 
the 6 patients, 5 (83.3%) showed improvement after SAE without 
complications. 
Conclusion: SAE may be a safe and effective procedure for controlling 
acute intractable hemorrhage in pediatric malignancy patients. 
This procedure may obviate the need for surgery, which carries an 
attendant risk of morbidity and mortality in cancer patients with critical 
conditions. 
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Introduction
Acute hemorrhage can be a life-threatening complication in cancer 
patients and is a significant cause of morbidity and mortality
1-3). 
It occurs in approximately 6-10% of cancer patients
3, 4). Medical 
treatment for acute hemorrhage includes compression, drug therapy, 
blood transfusion, hydration and other supportive care. Other 
therapeutic strategies include radiotherapy, surgical therapy, such as 
vessel ligation or the resection of hemorrhagic tissue
3). However, the 
inherent morbidity of the surgical procedures in debilitated patients, 
and the efficacy of medical treatment may make this approach 
problematic
3, 5). Therefore, selective arterial embolization (SAE) is 
increasingly preferred as a therapeutic procedure for controlling 
hemorrhage, normally in adults. Furthermore, SAE is applied 
increasingly in conditions, such as hemorrhage, arterio-venous 
malformation, arteriovenous fistula, aneurysm and tumors
6-9). 
However, SAE is performed less frequently in pediatric patients. This 
may be secondary to the stress of the procedure itself, lack of doctor`s 
experience and possible long-term side effects
8). Therefore, the aim 
of this retrospective study was to determine the efficacy and safety of 
SAE in the treatment of intractable hemorrhage in pediatric patients 
with malignancies.
Materials and methods
From January 2004 to December 2009, the medical records 
of 6 pediatric patients with a malignancy who underwent SAE of 
the internal iliac artery at Chonnam National University Hwasun 
Hospital were analyzed retrospectively. All patients presented 
with intractable hemorrhage, which had not responded to earlier 
conservative measures. Data on the following items were documented: 
general characteristics, underlying disease, treatment of underlying 
disease, number of SAE performed, response to SAE, side effects 
related to the procedure and follow-up duration. The complications 
related to the SAE procedure, including nausea, vomiting, fever, 
development of hematoma, infection, vascular perforation, ischemia, 
and pain were also examined. SAE was performed by an inter-
ventional radiologist under fluoroscopic guidance after patients had 
been appropriately sedated. The Gelfoam
Ⓡ (Pfizer Inc., New York, 
NY, USA) and/or Tornado
Ⓡ coils (Cook Inc., Bloomington, IN, 
USA) were used as embolic agents.
In cases of hemorrhagic cystitis (HC), the onset time and duration 
of HC before SAE were reviewed. HC was graded according to the 
criteria previously reported
9): grade 1, continuation of microscopic 
hematuria for more than 2 days; grade 2, gross hematuria; grade 
3, gross hematuria with a clot; grade 4, gross hematuria with renal 
impairment due to urinary tract obstruction with a clot. 
Results
1. General characteristics of the patients
Six patients with various malignancies were enrolled in this study: 
acute lymphocytic leukemia, acute myelogenous leukemia, chronic 
myelogenous leukemia, T-cell prolymphocytic leukemia, Langerhans 
cell histiocytosis and rhabdomyosarcoma. The median age was 
6.9 years (range, 0.7‒14.8 years). Five were males (83.3%). The 
median follow-up period was 9.5 months (range, 0.3‒24 months). 
The patient with rhabdomyosarcoma was treated by chemotherapy 
consisting of vincristine, dactinomycin and cyclophosphamide. The 
other 5 patients (83.3%) received allogeneic hematopoietic stem cell 
transplantation (HSCT). The stem cell sources for transplantation 
were umbilical cord blood, unrelated bone marrow and unrelated 
peripheral blood for 1 patient each and haploidentical bone marrow 
for 2 patients (Table 1). 
2. The causes of hemorrhage and initial treatment
In 3 of the 6 patients (50%), the cause of the hemorrhage was 
HC, which developed after allogeneic HSCT. Two patients (33.3%) 
Table 1. General Patient Characteristics and the Cause of Internal Pelvic Cavity Hemorrhage
UPN Gender
Age 
(years)
Underlying disease
Treatment for  
underlying disease
HSCT donor Cause of internal pelvic cavity hemorrhage
1
2
3
4
5
6
M
M
M
M
F
M
14.8
9.4
10.2
1.8
0.7
7.6
AML
CML
T-PLL 
LCH
ALL
Rhabdomyosarcoma
HSCT
HSCT
HSCT
HSCT
HSCT
IRS-IV chemotherapy
Haploidentical BM+ Mismatched  UCB
Matched unrelated BM
Haploidentical BM
Matched UCB 
Unrelated matched PB
(-)
HC
HC
HC
Injury of Rt. internal iliac artery
Injury of Lt. internal iliac artery
Rupture of  tumor
Abbreviations: UPN, unique patient number; M, male; F, female; AML, acute myelogenous leukemia; CML, chronic myelogenous leukemia; T-PLL, T-cell 
prolymphocytic leukemia; ALL, acute lymphocytic leukemia; LCH, Langerhans cell histiocytosis; IRS, Inter-group rhabdomyosarcoma study; HSCT, 
hematopoietic stem cell transplantation; BM, bone marrow; UCB, umbilical cord blood; PB, peripheral blood; HC, hemorrhagic cystitis.Korean J Pediatr 2011;54(4):169-175 • DOI: 10.3345/kjp.2011.54.4.175    171
had an iatrogenic iliac artery injury and the last patient had a tumor 
rupture (Table 1). For the children with HC, the median day of 
onset was 15 days after allogeneic HSCT (range, 13‒47 days), and 
the median duration of HC was 15 days (range, 9‒33 days) before 
SAE. Two patients had grade 3 HC and 1 had grade 4. For transplant 
conditioning, intravenous busulfan and cyclophosphamide were 
used in 2 patients with HC, and cyclophosphamide and total body 
irradiation were used in 1. Two patients were positive for both 
adenovirus type 2 and the BK virus in blood and urine, which are 
associated with HC. 
Before SAE was performed, numerous therapeutic approaches 
had been attempted. In cases of HC, all the measures, such as forced 
hydration over 3000 mL/m
2  per day,  platelet or red cell and fresh 
frozen plasma transfusions, Foley catheter insertion, instillation of 
sodium hyaluronate within the bladder, diuretics and antiviral agents 
were not able to control the bleeding (Table 2). Three patients with 
refractory hemorrhage due to internal iliac artery injury or tumor 
rupture did not respond to medical treatments including hydration, 
administration of blood products, inotropic agents and vitamin K 
administration, resulting in hypotension and markedly decreased 
hemoglobin (Hb) concentration (mean value, 5.1 g/dL). Surgery 
was generally not attempted because of high risk conditions, such as, 
low platelet counts less than 20,000/mm
3, prolonged PT/PTT and 
decreased neutrophil counts. In addition, active bleeding sites were 
able to be localized by angiography. Thus, SAE was attempted instead 
of surgery. 
3. Results of selective internal iliac artery embolization 
Of the 6 patients, 4 (66.7%) underwent bilateral SAE, and 2 
(33.3%) had unilateral SAE. Gelfoam
Ⓡ and/or Tornado
Ⓡ coils were 
used for embolization (Gelfoam
Ⓡ alone in 4 patients; Tornado
Ⓡ 
coils alone in 1; both Gelfoam
Ⓡ and Tornado
Ⓡ coils in 1). Five 
(83.3%) patients responded to SAE initially but repeat SAE was 
needed because the hemorrhage reappeared in 2 patients. There 
were no more recurrences after the repeated procedures. After SAE, 
it took a median interval of 6 days (range, 3-12 days) to control the 
bleeding. One patient who did not respond to SAE in addition to 
supportive measures died of hypotension caused by the uncontrolled 
bleeding 3 days after the procedure. During follow-up period, two 
more patients died from causes not related to bleeding: chronic graft-
versus-host disease 14 months after HSCT; and sepsis 3 months after 
transplantation. 
There were no significant immediate or late side effects associated 
with the SAE procedures, such as nausea, vomiting, fever, infection, 
Table 2. Characteristics of Patients with Hemorrhagic Cystitis
UPN
HC 
(Grade)
HC onset from HSCT
(days)
HC duration before SAE 
(days)
Conditioning regimen
Virus
Initial treatment 
Adenovirus Type II BK Virus
1
2
3
Median
4
4
3
13
47
15
15
  9
33
15
15
Busulfan (iv)
Cyclophosphamide
Busulfan (iv)
Cyclophosphamide
TBI
Cyclophosphamide
Blood PCR
Urine culture
Blood PCR
Blood PCR
Blood/Urine PCR
(-)
Urine PCR/culture
Supportive care
SH instillation
Supportive care
Supportive care
SH instillation
Supportive care: hydration, transfusion, Foley catheter insertion, diuretics
Abbreviations: UPN, unique patient number; HC, hemorrhagic cystitis; SAE, selective arterial embolization; HSCT, hematopoietic stem cell transplant; TBI, total 
body irradiation; PCR, polymerase chain reaction; SH, sodium hyaluronate.
Table 3. Outcomes of Selective Internal Iliac Artery Embolization
UPN    Site Materials Time to response (days) Follow-up duration (months) Number of procedures (times) Side effect Outcome
1 Bilateral Gelfoam
®   7   7 2 No Controlled
2 Bilateral Gelfoam
® 12 24 1 No Controlled
3 Bilateral Gelfoam
®   5   3 2 No Controlled
4 Unilateral Tornado
® coils    6 14 1 No Controlled
5 Unilateral Gelfoam
® NR 0.3 1 No Uncontrolled
6 Bilateral Gelfoam
®   3 12 1 No Controlled
Tornado
® coils 
Median    6 9.5
Abbreviations: UPN, Unique patient number; NR, no response. 172      SH Bae, et al. • Therapeutic selective arterial embolization for refractory hemorrhage in children
hematoma, vascular perforation, ischemia, paresthesia, claudication 
and pain in buttock or procedure site (Table 3, Fig. 1-3). 
Discussion
In cancer patients, acute hemorrhage is a well-known complication 
that is associated with high morbidity and mortality
3, 5). Various 
therapeutic approaches have been attempted including intensive 
supportive care with compression, hydration, blood transfusion, 
drug therapy and surgical care
3, 5, 9). However, there is no specific and 
effective treatment. Some patients do not respond to medical care
5, 11). 
Surgical treatment is the ultimate therapeutic approach for controlling 
refractory hemorrhage but is associated with high morbidity and 
mortality because of the poor general condition of the cancer patients 
or underlying disease as well as the complications arising from 
treatment of the underlying disease
2, 12). SAE is a minimally invasive 
procedure with a lower rate of morbidity, having obvious advantages 
over surgery. Therefore, it is an accepted approach and is used more 
often to treat intractable hemorrhage
5, 12, 13).
The SAE of the internal iliac artery was first reported in 1973 as 
a mean to control the bleeding associated with pelvic fractures
16). 
In 1974, Halad and Myging
17) were the first to describe the use of 
SAE of the internal iliac artery to control HC secondary to radiation 
therapy for bladder cancer. Since then, the indications for SAE 
of the internal iliac artery to control intractable hemorrhage have 
widened
18), including the management of hemorrhage resulting 
from trauma, iatrogenic or obstetrical causes, and pelvic or urological 
neoplasm
2, 5, 9, 14, 15, 19). In this study, all 6 children had an acute pelvic 
cavity hemorrhage resulting from HC, iatrogenic vascular injuries 
or rupture of a retroperitoneal tumor, which could not be controlled 
Fig. 1. Image of the vesical arteries before and after embolization (Patient 1). A) Selective 
angiography of the right internal iliac artery before embolization shows prominent 
hypervascularization at the level of the left vesical arteries. B) Angiography findings of the 
internal iliac artery after embolization with Gelfoam
® show improved hypervascularization of 
the left vesical arteries. 
Fig. 2. Angiography showing the right internal iliac artery in patient 4. A) Selective angiography 
revealed active bleeding from the right internal iliac artery (arrow) before embolization. B) The 
bleeding was markedly reduced after selective internal iliac artery embolization with multiple 
microcoils. Korean J Pediatr 2011;54(4):169-175 • DOI: 10.3345/kjp.2011.54.4.175    173
by medical treatment. SAE of the internal iliac artery was attempted 
as surgical therapy was impossible due to the poor general condition 
of the patients and their low platelet counts. The bleeding was 
brought under control in 5 of the 6 patients (83.3%) after SAE. The 
remaining one patient died of uncontrollable bleeding despite the 
SAE procedure because of poor general condition associated with 
underlying hypotensive shock. These results are similar to those of 
previous studies showing the efficacy of SAE
2, 5, 9, 11, 12, 14, 15). 
According to Han et al.
5), 10 patients with grade 3‒4 HC following 
allogeneic HSCT underwent SAE of the internal iliac artery. The 
unsuccessful medical treatments performed before SAE included 
the following: hyperhydration, blood transfusion, intravesical 
instillation of granulocyte, monocyte-colony stimulating factor, 
bladder irrigation, and antiviral agents. Eight patients responded to 
SAE within 15 days. Surgical treatment, such as cauterization with 
cystoscopy or cystectomy, was not necessary
5). There were several 
reports about successful SAE; 2 adults with HC who received an 
allogeneic HSCT
2) and 6 patients (mean age 80 years) with bladder 
or prostate carcinoma, who all patients were embolized successfully 
within 8 days and without complications
12). SAE was also performed 
successfully in instances of severe postpartum hemorrhage, pelvic 
fracture or trauma
15, 20).
During the follow-up period, 2 children underwent a second SAE 
due to a relapse of the hemorrhage but there were no recurrences 
after the second procedure. This finding is comparable to that of 
other studies. In the recent study, 6 adult patients were reported 
who underwent selective embolization of the bladder arteries for 
treatment of incoercible hematuria. All patients with hematuria 
responded within 48 hours after the procedure, but two patients had 
a recurrence of the bleeding that required a second procedure
21). In 
2007 report, among 7 patients with intractable bladder hemorrhage 
who underwent internal iliac artery embolization, but bleeding 
was controlled permanently in 4 (57%) patients and a second 
embolization was required in 1 patient
22). In the other study of 44 
patients with an advanced pelvic tumor (mean age 79 years; range 
51‒95), the initial embolization produced complete control of the 
bleeding in 36 of the 44 patients (82%). However, subsequent arterial 
embolization was required in 5 patients (11%) and was successful
23). 
In addition, this procedure can also be used to diagnose and treat 
aneurysms, arterio-venous malformation or tumors
6, 24, 25). 
However, SAE is performed less frequently in children, particularly 
in pediatric cancer patients
6-8, 24). A search of the literature on SAE 
in the pediatric population revealed only a few reports. Legge et al.
8) 
performed SAE in 5 pediatric patients suffering from hypersplenism, 
hemobilia, sigmoid hemangioma and aneurysmal bone cysts in 
the iliac bone. Embolization provided definitive treatment in all 
cases without complications. Bilateral internal pudendal artery 
embolization was performed for intractable priapism in a 14- year-
old boy with chronic myelogenous leukemia
7). A month-old baby 
with a mycotic internal iliac aneurysm underwent successful coil 
embolization
6). Erkan
24) also carried out SAE for the treatment 
of pelvic aneurysmal bone cysts in two children. Along with the 
reported cases, our data on 6 patients support the effectiveness of 
SAE for the treatment of refractory hemorrhage in children with a 
malignancy.
A range of materials have been used for embolization including 
muscle, autologous clots, gelatin, coil, and balloon
26). Gelfoam
Ⓡ 
and/or coil were used for embolization. Gelfoam
Ⓡ, a gelatin sponge, 
is a water-insoluble hemostatic material that is easy to handle. It is 
biodegradable or absorbable, and the vessel recanalizes within a few 
weeks. Consequently, it has fewer complications of vascular occlusion 
than using coil or surgical vessel ligation
8, 26). A coil is effective 
Fig. 3. A) Abdominal computerized tomography scan showing a large retroperitoneal hematoma 
and active bleeding in the iliopsoas area of the right pelvis due to an iatrogenic internal arterial 
injury (patient 4). B) Fourteen days after selective internal arterial embolization, right pelvic and 
lower abdominal retroperitoneal hematoma was markedly reabsorbed. 174      SH Bae, et al. • Therapeutic selective arterial embolization for refractory hemorrhage in children
either for fast flowing vessels or when needed to occlude a vessel 
permanently
23).
The complications associated with SAE include nausea, vomiting, 
fever, infection, pain, hematoma, vascular perforation, chills, 
claudication, erectile dysfunction, urinary retention, and paresthesia
5, 
12, 17, 26-28). However, serious side effects are rare
26, 29) and can be 
reduced by precise placement of the coil or Gelfoam
Ⓡ to preserve 
tissue perfusion
12, 21, 30). In the current study, there were no side effects 
encountered during the follow-up period, but it will be necessary to 
carefully observe these patients for possible long-term complications, 
such as claudication, sexual dysfunction and paresthesia
26-28).
In conclusion, bleeding was controlled in 5 out of 6 children 
(83.3%) after SAE of the internal iliac artery without side effects. 
The results suggest that SAE of the internal iliac artery is an effective 
and safe therapeutic approach in pediatric cancer patients with 
hemorrhage who do not respond to supportive care. SAE can also 
reduce the patients` exposure to the risks inherent with the surgical 
procedures. Further clinical trials involving a larger number of 
patients will be needed to evaluate the potential role, safety and 
possible long-term side effects of SAE in children with malignancies. 
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